Frontlight ResearchEarly access
Fatty liver disease (MASLD/MASH) trials in Norway
1 of 2 trials · From ClinicalTrials.gov, checked 16 November 2026. Ask the study team whether a trial fits you.
- No phaseNot yet taking people in NorwayDetecting Liver Fibrosis in Patients At-risk
- Where
- Stavanger
- Age
- 40 years to 70 years
- People
- 1,200
- Run by
- Helse Stavanger HF
See details and how to joinNCT07775638